HEADER HYDROLASE 18-DEC-05 2FF1 TITLE CRYSTAL STRUCTURE OF TRYPANOSOMA VIVAX NUCLEOSIDE HYDROLASE SOAKED TITLE 2 WITH IMMUCILLINH COMPND MOL_ID: 1; COMPND 2 MOLECULE: IAG-NUCLEOSIDE HYDROLASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IAG-NH; COMPND 5 EC: 3.2.2.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA VIVAX; SOURCE 3 ORGANISM_TAXID: 5699; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: WK6; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PQE-30 KEYWDS ROSSMANN FOLD, DISORDERED LOOPS, AROMATIC STACKING, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR W.VERSEES,J.BARLOW,J.STEYAERT REVDAT 3 05-OCT-22 2FF1 1 REMARK SEQADV HETSYN LINK REVDAT 2 24-FEB-09 2FF1 1 VERSN REVDAT 1 23-MAY-06 2FF1 0 JRNL AUTH W.VERSEES,J.BARLOW,J.STEYAERT JRNL TITL TRANSITION-STATE COMPLEX OF THE PURINE-SPECIFIC NUCLEOSIDE JRNL TITL 2 HYDROLASE OF T.VIVAX: ENZYME CONFORMATIONAL CHANGES AND JRNL TITL 3 IMPLICATIONS FOR CATALYSIS. JRNL REF J.MOL.BIOL. V. 359 331 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16630632 JRNL DOI 10.1016/J.JMB.2006.03.026 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 36184 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM (SAME SET OF REMARK 3 REFLECTIONS AS FOR PDB ENTRY REMARK 3 1HOZ) REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1784 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.07 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2354 REMARK 3 BIN FREE R VALUE : 0.2956 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 56 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4831 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 378 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.554 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FF1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000035800. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-NOV-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9322 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39979 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.850 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: ISOMORPHOUS TO PDB ENTRY REMARK 200 1HOZ REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6 M AMMONIUM SULPHATE, 100 MM TRIS , REMARK 280 PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.55500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS THE BIOLOGICALLY RELEVANT REMARK 300 HOMODIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -12 REMARK 465 ARG A -11 REMARK 465 GLY A -10 REMARK 465 SER A -9 REMARK 465 PRO A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A -1 REMARK 465 CYS A 245 REMARK 465 THR A 246 REMARK 465 HIS A 247 REMARK 465 CYS A 248 REMARK 465 GLU A 249 REMARK 465 LEU A 250 REMARK 465 LEU A 251 REMARK 465 ARG A 252 REMARK 465 ASP A 253 REMARK 465 GLY A 254 REMARK 465 ASP A 255 REMARK 465 GLY A 256 REMARK 465 TYR A 257 REMARK 465 MET B -12 REMARK 465 ARG B -11 REMARK 465 GLY B -10 REMARK 465 SER B -9 REMARK 465 PRO B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 GLY B -1 REMARK 465 CYS B 245 REMARK 465 THR B 246 REMARK 465 HIS B 247 REMARK 465 CYS B 248 REMARK 465 GLU B 249 REMARK 465 LEU B 250 REMARK 465 LEU B 251 REMARK 465 ARG B 252 REMARK 465 ASP B 253 REMARK 465 GLY B 254 REMARK 465 ASP B 255 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 GLU A 82 CG CD OE1 OE2 REMARK 470 GLU A 129 CG CD OE1 OE2 REMARK 470 LYS A 272 CG CD CE NZ REMARK 470 GLU A 300 CG CD OE1 OE2 REMARK 470 GLU B 27 CD OE1 OE2 REMARK 470 LYS B 81 CG CD CE NZ REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 470 LEU B 86 CG CD1 CD2 REMARK 470 LYS B 88 CG CD CE NZ REMARK 470 GLU B 129 CG CD OE1 OE2 REMARK 470 GLU B 130 CG CD OE1 OE2 REMARK 470 LYS B 153 CD CE NZ REMARK 470 ARG B 171 CD NE CZ NH1 NH2 REMARK 470 LYS B 272 CG CD CE NZ REMARK 470 ARG B 309 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TRP B 83 N CYS B 85 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 85 N - CA - C ANGL. DEV. = 20.0 DEGREES REMARK 500 LEU B 86 N - CA - C ANGL. DEV. = -16.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 39 -84.04 -112.93 REMARK 500 CYS A 41 -178.76 -172.04 REMARK 500 VAL A 168 -62.15 -98.69 REMARK 500 ASP A 190 75.21 -155.24 REMARK 500 ALA A 259 39.11 -90.78 REMARK 500 TRP A 260 -70.98 -32.61 REMARK 500 LYS A 287 44.53 -85.69 REMARK 500 ASN A 310 61.52 38.69 REMARK 500 ALA B 39 -94.85 -104.34 REMARK 500 ASP B 40 40.98 -80.02 REMARK 500 VAL B 43 -39.18 -38.09 REMARK 500 MET B 61 19.25 -147.58 REMARK 500 ARG B 84 74.19 -51.08 REMARK 500 CYS B 85 140.24 53.48 REMARK 500 ALA B 167 116.60 -160.39 REMARK 500 VAL B 168 -62.40 -98.17 REMARK 500 ASP B 190 84.18 -153.15 REMARK 500 ALA B 259 51.12 -90.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 601 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 10 OD2 REMARK 620 2 ASP A 15 OD1 68.2 REMARK 620 3 ASP A 15 OD2 70.2 52.5 REMARK 620 4 THR A 137 O 100.6 81.6 133.7 REMARK 620 5 ASP A 261 OD2 145.6 82.7 77.7 92.6 REMARK 620 6 IMH A 401 O3' 140.7 143.8 141.9 72.7 73.6 REMARK 620 7 IMH A 401 O2' 111.2 134.2 83.2 138.7 76.0 65.9 REMARK 620 8 HOH A 602 O 70.2 135.3 124.5 90.6 141.9 71.1 76.7 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 602 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 10 OD2 REMARK 620 2 ASP B 15 OD1 71.1 REMARK 620 3 ASP B 15 OD2 76.8 50.8 REMARK 620 4 THR B 137 O 100.0 83.7 133.3 REMARK 620 5 ASP B 261 OD2 143.5 75.0 71.5 89.1 REMARK 620 6 IMH B 402 O3' 141.3 135.5 140.4 64.4 74.4 REMARK 620 7 IMH B 402 O2' 120.9 133.0 85.8 130.4 74.7 66.1 REMARK 620 8 HOH B 802 O 69.0 137.8 128.8 90.2 146.9 75.6 80.8 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMH A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMH B 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HOZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE- PREFERRING REMARK 900 NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX REMARK 900 RELATED ID: 1HP0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN INOSINE-ADENOSINE-GUANOSINE- PREFERRING REMARK 900 NUCLEOSIDE HYDROLASE FROM TRYPANOSOMA VIVAX IN COMPLEX WITH THE REMARK 900 SUBSTRATE ANALOGUE 3-DEAZA-ADENOSINE REMARK 900 RELATED ID: 1KIC RELATED DB: PDB REMARK 900 INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM REMARK 900 TRYPANOSOMA VIVAX: ASP10ALA MUTANT IN COMPLEX WITH INOSINE REMARK 900 RELATED ID: 1KIE RELATED DB: PDB REMARK 900 INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM REMARK 900 TRYPANOSOMA VIVAX: ASP10ALA MUTANT IN COMPLEX WITH 3- DEAZA- REMARK 900 ADENOSINE REMARK 900 RELATED ID: 1R4F RELATED DB: PDB REMARK 900 INOSINE-ADENOSINE-GUANOSINE PREFERRING NUCLEOSIDE HYDROLASE FROM REMARK 900 TRYPANOSOMA VIVAX: TRP260ALA MUTANT IN COMPLEX WITH 3- DEAZA- REMARK 900 ADENOSINE REMARK 900 RELATED ID: 2MAS RELATED DB: PDB REMARK 900 PURINE NUCLEOSIDE HYDROLASE WITH A TRANSITION STATE INHIBITOR DBREF 2FF1 A 0 327 UNP Q9GPQ4 Q9GPQ4_TRYVI 2 327 DBREF 2FF1 B 0 327 UNP Q9GPQ4 Q9GPQ4_TRYVI 2 327 SEQADV 2FF1 MET A -12 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 ARG A -11 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 GLY A -10 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 SER A -9 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 PRO A -8 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS A -7 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS A -6 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS A -5 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS A -4 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS A -3 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS A -2 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 GLY A -1 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 SER A 0 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 ASN A 214 UNP Q9GPQ4 LYS 301 SEE REMARK 999 SEQADV 2FF1 MET B -12 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 ARG B -11 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 GLY B -10 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 SER B -9 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 PRO B -8 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS B -7 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS B -6 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS B -5 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS B -4 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS B -3 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 HIS B -2 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 GLY B -1 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 SER B 0 UNP Q9GPQ4 EXPRESSION TAG SEQADV 2FF1 ASN B 214 UNP Q9GPQ4 LYS 301 SEE REMARK 999 SEQRES 1 A 339 MET ARG GLY SER PRO HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 A 339 ALA LYS ASN VAL VAL LEU ASP HIS ASP GLY ASN LEU ASP SEQRES 3 A 339 ASP PHE VAL ALA MET VAL LEU LEU ALA SER ASN THR GLU SEQRES 4 A 339 LYS VAL ARG LEU ILE GLY ALA LEU CYS THR ASP ALA ASP SEQRES 5 A 339 CYS PHE VAL GLU ASN GLY PHE ASN VAL THR GLY LYS ILE SEQRES 6 A 339 MET CYS LEU MET HIS ASN ASN MET ASN LEU PRO LEU PHE SEQRES 7 A 339 PRO ILE GLY LYS SER ALA ALA THR ALA VAL ASN PRO PHE SEQRES 8 A 339 PRO LYS GLU TRP ARG CYS LEU ALA LYS ASN MET ASP ASP SEQRES 9 A 339 MET PRO ILE LEU ASN ILE PRO GLU ASN VAL GLU LEU TRP SEQRES 10 A 339 ASP LYS ILE LYS ALA GLU ASN GLU LYS TYR GLU GLY GLN SEQRES 11 A 339 GLN LEU LEU ALA ASP LEU VAL MET ASN SER GLU GLU LYS SEQRES 12 A 339 VAL THR ILE CYS VAL THR GLY PRO LEU SER ASN VAL ALA SEQRES 13 A 339 TRP CYS ILE ASP LYS TYR GLY GLU LYS PHE THR SER LYS SEQRES 14 A 339 VAL GLU GLU CYS VAL ILE MET GLY GLY ALA VAL ASP VAL SEQRES 15 A 339 ARG GLY ASN VAL PHE LEU PRO SER THR ASP GLY THR ALA SEQRES 16 A 339 GLU TRP ASN ILE TYR TRP ASP PRO ALA SER ALA LYS THR SEQRES 17 A 339 VAL PHE GLY CYS PRO GLY LEU ARG ARG ILE MET PHE SER SEQRES 18 A 339 LEU ASP SER THR ASN THR VAL PRO VAL ARG SER PRO TYR SEQRES 19 A 339 VAL GLN ARG PHE GLY GLU GLN THR ASN PHE LEU LEU SER SEQRES 20 A 339 ILE LEU VAL GLY THR MET TRP ALA MET CYS THR HIS CYS SEQRES 21 A 339 GLU LEU LEU ARG ASP GLY ASP GLY TYR TYR ALA TRP ASP SEQRES 22 A 339 ALA LEU THR ALA ALA TYR VAL VAL ASP GLN LYS VAL ALA SEQRES 23 A 339 ASN VAL ASP PRO VAL PRO ILE ASP VAL VAL VAL ASP LYS SEQRES 24 A 339 GLN PRO ASN GLU GLY ALA THR VAL ARG THR ASP ALA GLU SEQRES 25 A 339 ASN TYR PRO LEU THR PHE VAL ALA ARG ASN PRO GLU ALA SEQRES 26 A 339 GLU PHE PHE LEU ASP MET LEU LEU ARG SER ALA ARG ALA SEQRES 27 A 339 CYS SEQRES 1 B 339 MET ARG GLY SER PRO HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 B 339 ALA LYS ASN VAL VAL LEU ASP HIS ASP GLY ASN LEU ASP SEQRES 3 B 339 ASP PHE VAL ALA MET VAL LEU LEU ALA SER ASN THR GLU SEQRES 4 B 339 LYS VAL ARG LEU ILE GLY ALA LEU CYS THR ASP ALA ASP SEQRES 5 B 339 CYS PHE VAL GLU ASN GLY PHE ASN VAL THR GLY LYS ILE SEQRES 6 B 339 MET CYS LEU MET HIS ASN ASN MET ASN LEU PRO LEU PHE SEQRES 7 B 339 PRO ILE GLY LYS SER ALA ALA THR ALA VAL ASN PRO PHE SEQRES 8 B 339 PRO LYS GLU TRP ARG CYS LEU ALA LYS ASN MET ASP ASP SEQRES 9 B 339 MET PRO ILE LEU ASN ILE PRO GLU ASN VAL GLU LEU TRP SEQRES 10 B 339 ASP LYS ILE LYS ALA GLU ASN GLU LYS TYR GLU GLY GLN SEQRES 11 B 339 GLN LEU LEU ALA ASP LEU VAL MET ASN SER GLU GLU LYS SEQRES 12 B 339 VAL THR ILE CYS VAL THR GLY PRO LEU SER ASN VAL ALA SEQRES 13 B 339 TRP CYS ILE ASP LYS TYR GLY GLU LYS PHE THR SER LYS SEQRES 14 B 339 VAL GLU GLU CYS VAL ILE MET GLY GLY ALA VAL ASP VAL SEQRES 15 B 339 ARG GLY ASN VAL PHE LEU PRO SER THR ASP GLY THR ALA SEQRES 16 B 339 GLU TRP ASN ILE TYR TRP ASP PRO ALA SER ALA LYS THR SEQRES 17 B 339 VAL PHE GLY CYS PRO GLY LEU ARG ARG ILE MET PHE SER SEQRES 18 B 339 LEU ASP SER THR ASN THR VAL PRO VAL ARG SER PRO TYR SEQRES 19 B 339 VAL GLN ARG PHE GLY GLU GLN THR ASN PHE LEU LEU SER SEQRES 20 B 339 ILE LEU VAL GLY THR MET TRP ALA MET CYS THR HIS CYS SEQRES 21 B 339 GLU LEU LEU ARG ASP GLY ASP GLY TYR TYR ALA TRP ASP SEQRES 22 B 339 ALA LEU THR ALA ALA TYR VAL VAL ASP GLN LYS VAL ALA SEQRES 23 B 339 ASN VAL ASP PRO VAL PRO ILE ASP VAL VAL VAL ASP LYS SEQRES 24 B 339 GLN PRO ASN GLU GLY ALA THR VAL ARG THR ASP ALA GLU SEQRES 25 B 339 ASN TYR PRO LEU THR PHE VAL ALA ARG ASN PRO GLU ALA SEQRES 26 B 339 GLU PHE PHE LEU ASP MET LEU LEU ARG SER ALA ARG ALA SEQRES 27 B 339 CYS HET CA A 601 1 HET IMH A 401 19 HET CA B 602 1 HET IMH B 402 19 HETNAM CA CALCIUM ION HETNAM IMH 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN-9-YL)-D- HETNAM 2 IMH RIBITOL HETSYN IMH FORODESINE; IMMUCILLIN H FORMUL 3 CA 2(CA 2+) FORMUL 4 IMH 2(C11 H14 N4 O4) FORMUL 7 HOH *378(H2 O) HELIX 1 1 ASN A 12 ASN A 25 1 14 HELIX 2 2 PHE A 42 ASN A 59 1 18 HELIX 3 3 PRO A 80 CYS A 85 1 6 HELIX 4 4 CYS A 85 ASP A 92 1 8 HELIX 5 5 MET A 93 ASN A 97 5 5 HELIX 6 6 ILE A 98 LYS A 114 1 17 HELIX 7 7 GLU A 116 ASN A 127 1 12 HELIX 8 8 LEU A 140 GLY A 151 1 12 HELIX 9 9 GLY A 151 SER A 156 1 6 HELIX 10 10 GLU A 184 TRP A 189 1 6 HELIX 11 11 ASP A 190 GLY A 199 1 10 HELIX 12 12 SER A 209 ASN A 214 1 6 HELIX 13 13 ARG A 219 ARG A 225 1 7 HELIX 14 14 PHE A 226 THR A 230 5 5 HELIX 15 15 PHE A 232 MET A 244 1 13 HELIX 16 16 ALA A 259 ASP A 270 1 12 HELIX 17 17 GLN A 271 ALA A 274 5 4 HELIX 18 18 GLU A 312 ALA A 324 1 13 HELIX 19 19 ASN B 12 ASN B 25 1 14 HELIX 20 20 PHE B 42 ASN B 62 1 21 HELIX 21 21 LEU B 86 ASP B 92 1 7 HELIX 22 22 MET B 93 ASN B 97 5 5 HELIX 23 23 ILE B 98 LYS B 114 1 17 HELIX 24 24 GLU B 116 SER B 128 1 13 HELIX 25 25 LEU B 140 GLY B 151 1 12 HELIX 26 26 GLY B 151 SER B 156 1 6 HELIX 27 27 GLU B 184 ASP B 190 1 7 HELIX 28 28 ASP B 190 GLY B 199 1 10 HELIX 29 29 SER B 209 ASN B 214 1 6 HELIX 30 30 ARG B 219 ARG B 225 1 7 HELIX 31 31 PHE B 226 THR B 230 5 5 HELIX 32 32 PHE B 232 MET B 244 1 13 HELIX 33 33 ALA B 259 ASP B 270 1 12 HELIX 34 34 GLN B 271 ALA B 274 5 4 HELIX 35 35 GLU B 312 ALA B 324 1 13 SHEET 1 A 9 ILE A 68 LYS A 70 0 SHEET 2 A 9 VAL A 29 CYS A 36 1 N CYS A 36 O GLY A 69 SHEET 3 A 9 LYS A 3 HIS A 9 1 N LYS A 3 O ARG A 30 SHEET 4 A 9 VAL A 132 VAL A 136 1 O THR A 133 N ASN A 4 SHEET 5 A 9 VAL A 158 MET A 164 1 O VAL A 162 N ILE A 134 SHEET 6 A 9 ARG A 205 PHE A 208 1 O PHE A 208 N ILE A 163 SHEET 7 A 9 LEU A 304 ARG A 309 1 O PHE A 306 N MET A 207 SHEET 8 A 9 ASN A 275 VAL A 283 -1 N ASP A 277 O VAL A 307 SHEET 9 A 9 THR A 294 ARG A 296 -1 O VAL A 295 N ASP A 282 SHEET 1 B 9 ILE B 68 LYS B 70 0 SHEET 2 B 9 VAL B 29 CYS B 36 1 N CYS B 36 O GLY B 69 SHEET 3 B 9 LYS B 3 HIS B 9 1 N LYS B 3 O ARG B 30 SHEET 4 B 9 VAL B 132 VAL B 136 1 O CYS B 135 N ASP B 8 SHEET 5 B 9 VAL B 158 MET B 164 1 O VAL B 162 N VAL B 136 SHEET 6 B 9 ARG B 205 PHE B 208 1 O PHE B 208 N ILE B 163 SHEET 7 B 9 LEU B 304 ARG B 309 1 O PHE B 306 N MET B 207 SHEET 8 B 9 ASN B 275 VAL B 283 -1 N VAL B 279 O THR B 305 SHEET 9 B 9 THR B 294 ARG B 296 -1 O VAL B 295 N ASP B 282 LINK OD2 ASP A 10 CA CA A 601 1555 1555 2.60 LINK OD1 ASP A 15 CA CA A 601 1555 1555 2.58 LINK OD2 ASP A 15 CA CA A 601 1555 1555 2.37 LINK O THR A 137 CA CA A 601 1555 1555 2.41 LINK OD2 ASP A 261 CA CA A 601 1555 1555 2.58 LINK O3' IMH A 401 CA CA A 601 1555 1555 2.41 LINK O2' IMH A 401 CA CA A 601 1555 1555 2.61 LINK CA CA A 601 O HOH A 602 1555 1555 2.46 LINK OD2 ASP B 10 CA CA B 602 1555 1555 2.53 LINK OD1 ASP B 15 CA CA B 602 1555 1555 2.65 LINK OD2 ASP B 15 CA CA B 602 1555 1555 2.49 LINK O THR B 137 CA CA B 602 1555 1555 2.45 LINK OD2 ASP B 261 CA CA B 602 1555 1555 2.57 LINK O3' IMH B 402 CA CA B 602 1555 1555 2.59 LINK O2' IMH B 402 CA CA B 602 1555 1555 2.46 LINK CA CA B 602 O HOH B 802 1555 1555 2.51 SITE 1 AC1 6 ASP A 10 ASP A 15 THR A 137 ASP A 261 SITE 2 AC1 6 IMH A 401 HOH A 602 SITE 1 AC2 6 ASP B 10 ASP B 15 THR B 137 ASP B 261 SITE 2 AC2 6 IMH B 402 HOH B 802 SITE 1 AC3 14 ASN A 12 ASP A 14 ASP A 15 ASP A 40 SITE 2 AC3 14 TRP A 83 THR A 137 MET A 164 ASN A 173 SITE 3 AC3 14 GLU A 184 ASN A 186 TRP A 260 ASP A 261 SITE 4 AC3 14 CA A 601 HOH A 602 SITE 1 AC4 15 ASN B 12 ASP B 14 ASP B 15 ASP B 40 SITE 2 AC4 15 TRP B 83 THR B 137 MET B 164 ASN B 173 SITE 3 AC4 15 GLU B 184 ASN B 186 TYR B 257 TRP B 260 SITE 4 AC4 15 ASP B 261 CA B 602 HOH B 799 CRYST1 51.500 73.110 82.350 90.00 104.10 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019417 0.000000 0.004877 0.00000 SCALE2 0.000000 0.013678 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012521 0.00000